David A Fiellin
Overview
Explore the profile of David A Fiellin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
348
Citations
8597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belitzky E, Ravani Carvalho L, Taylor M, Ortiz C, Baum L, Fiellin D, et al.
Cancer Med
. 2025 Mar;
14(5):e70586.
PMID: 40052631
Purpose: To evaluate the current level of evidence for the use of psychedelics for the management of cancer pain and associated psychological distress. Content: Pain is a common symptom of...
2.
Farokhnia M, Tazare J, Pince C, Bruns Vi N, Gray J, Lo Re Iii V, et al.
J Clin Invest
. 2025 Mar;
PMID: 40048376
Background: Despite growing preclinical evidence that glucagon-like peptide-1 receptor agonists (GLP-1RAs) could be repurposed to treat alcohol use disorder (AUD), clinical evidence is scarce. Additionally, the potential impact of dipeptidyl...
3.
Pytell J, Fiellin D
J Addict Med
. 2025 Feb;
PMID: 39961057
As opioid-related mortality has increased in the United States, greater emphasis has been placed on ensuring access to medications for opioid use disorder(MOUD) and improving outcomes. While abstinence using urine...
4.
Lu H, Li F, Lesko C, Fink D, Rudolph K, Harhay M, et al.
Int J Epidemiol
. 2025 Jan;
54(1).
PMID: 39868475
Observational studies play an increasingly important role in estimating causal effects of a treatment or an exposure, especially with the growing availability of routinely collected real-world data. To facilitate drawing...
5.
Cohen S, Kashyap N, Steel T, Edelman E, Fiellin D, Joudrey P
J Hosp Med
. 2024 Nov;
PMID: 39580659
Background: Treatment of alcohol withdrawal syndrome (AWS) in hospitals is inconsistent. Electronic health record (EHR) order sets protocolize care. Objective: We examined variation in AWS order sets across hospital organizations...
6.
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E, et al.
Ann Emerg Med
. 2024 Nov;
85(3):205-213.
PMID: 39570250
Study Objective(s): To evaluate the cost-effectiveness of implementation facilitation compared with a standard educational strategy to promote emergency department (ED)-initiated buprenorphine with linkage to ongoing opioid use disorder care in...
7.
Cohen S, Beetham T, Fiellin D, Muvvala S
JAMA Netw Open
. 2024 Nov;
7(11):e2444679.
PMID: 39535800
No abstract available.
8.
Sung M, Black A, Blevins D, Henry B, Cates-Wessel K, Dawes M, et al.
J Addict Med
. 2024 Oct;
19(2):150-156.
PMID: 39475119
Background: Alternative models for methadone delivery outside of federal and state-regulated opioid treatment programs may improve access. We determined factors associated with clinician support for continuing office-based methadone. Methods: We...
9.
Womack J, Leblanc M, Sager A, Zaets L, Maisto S, Garcia A, et al.
AIDS Behav
. 2024 Oct;
29(2):482-496.
PMID: 39465468
Among persons with HIV (PWH), unhealthy alcohol use and polypharmacy contribute to bothersome symptoms (e.g., fatigue, dizziness, memory loss). However, effective risk communication targeting these associations is challenging. The HIV...
10.
Fiellin D
J Addict Med
. 2024 Oct;
18(5):480-482.
PMID: 39356618
In this issue, Strain advocates for the field of addiction medicine to consider a new diagnostic signal-treatment-refractory addiction. Also in this issue, Nunes and McLellan support the concepts advanced by...